

Simplexa™ Flu A/B & RSV Kit
Reliable detection and differentiation of influenza A virus, influenza B virus and RSV

Overview
Background
The CDC estimates that influenza has resulted in up to 35.6 million illnesses, 710,000 hospitalizations, and as many as 56,000 deaths annually since 2010.1
Respiratory syncytial virus (RSV) infection is more prevalent in infants and toddlers and is a leading cause of hospitalization in this age group, but RSV also causes disease in adults that can be severe in certain populations.2
1. https://www.cdc.gov/flu/about/disease/burden.htm
2. MOL2650, SimplexaTM Flu A/B & RSV Direct Kit Product Insert, Rev. F.
Why to choose it
Capable of running 94 patient samples at the same time.
For use on
Benefits
92 strains
DiaSorin Molecular is committed to ongoing monitoring and testing of emerging flu strains to ensure the most comprehensive strain coverage
92 strains have been validated, with more strains tested regularly to provide confidence in your results.
CURRENT STRAIN MONITORING
2016/2017 VACCINE STRAINS |
---|
2016/2017 vaccine strains A/California/7/2009 (H1N1)-like virusV |
A/Hong Kong/4801/2014 (H3N2)-like virus T |
B/Brisbane/60/2008-like virusV |
B/Phuket/3073/2013-like virus V* |
2017/2018 VACCINE STRAINS |
---|
2017/2018 vaccine strains A/Michigan/45/2015 (H1N1)pdm09-like virusR |
A/Hong Kong/4801/2014 (H3N2)-like virus T |
B/Brisbane/60/2008-like virusV |
B/Phuket/3073/2013-like virus V* |
V = Validated and in FDA cleared PI T = Tested but not submitted to FDA to revise PI R = Recently ordered from IRR, will be tested * in quadrivalent vaccine |
Reliable performance that you can count on
SimplexaTM Flu A/B & RSV assay has 100% sensitivity and greater than 98% specificity.
SimplexaTM Flu A/B and Culture/DFA Clinical Agreement
Influenza A
Clinical Agreement | Prospective Samples |
Retrospective Samples |
---|---|---|
Clinical Agreement Sensitivity | Prospective Samples 100% |
Retrospective Samples 100% |
Clinical Agreement Specificity | Prospective Samples 99.3% |
Retrospective Samples 100% |
Influenza B
Clinical Agreement | Prospective Samples |
Retrospective Samples |
---|---|---|
Clinical Agreement Sensitivity | Prospective Samples 100% |
Retrospective Samples 100% |
Clinical Agreement Specificity | Prospective Samples 99.8% |
Retrospective Samples 100% |
RSV
Clinical Agreement | Prospective Samples |
Retrospective Samples |
---|---|---|
Clinical Agreement Sensitivity | Prospective Samples 98.0% |
Retrospective Samples 100% |
Clinical Agreement Specificity | Prospective Samples 96.9% |
Retrospective Samples 96.0% |
Ordering info
Product | Code | Reactions |
---|---|---|
Product SimplexaTM Flu A/B & RSV Kit |
Code MOL2600 | Reactions 100 |
Our repository
All the answers you need.
Access our database to find:
instructions for use, safety data sheets,
assay protocols and more.